Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Company Stock Begins Trading on OTCBB LEXINGTON, Mass., Dec. 28 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC:MCHM.OB) (BULLETIN BOARD:...
Company Continues Trading on Pink Sheets and Seeks to Move to OTC Bulletin Board LEXINGTON, Mass., Nov. 21 /PRNewswire-FirstCall/ -- MacroChem...
LEXINGTON, Mass., Oct. 24 /PRNewswire-FirstCall/ -- MacroChem Corporation (NASDAQ:MCHM) today announced that the Company received a Nasdaq Staff...
LEXINGTON, Mass., Sept. 1 /PRNewswire-FirstCall/ -- At the direction of its board of directors, MacroChem Corporation (NASDAQ:MCHM) is...
MacroChem CEO Reports on Year of Progress and Innovation at Annual Shareholders' Meeting BOSTON, June 14 /PRNewswire-FirstCall/ -- MacroChem...
MacroChem Reports Positive Results From Clinical Trial of Opterone(R) Topical Testosterone Cream* 2.5 Grams of Opterone, Applied to Upper Arms and...
MacroChem Presents EcoNail(TM) Clinical Data at Society for Investigative Dermatology Annual Meeting (1) LEXINGTON, Mass., May 6 /PRNewswire/...
MacroChem Completes Private Placement LEXINGTON, Mass., April 20 /PRNewswire-FirstCall/ -- MacroChem Corporation (NasdaqSC: MCHM), announced...
MacroChem to Present EcoNail(TM) Clinical Data at Society For Investigative Dermatology Meeting Full 18-week data set confirms 6-week...
MacroChem Corporation Complies With Nasdaq Rule Regarding Recently Filed 10-K LEXINGTON, Mass., April 1 /PRNewswire-FirstCall/ -- In accordance...
MacroChem CEO to Present March 16 in Boston at Sachs-Bloomberg Forum: Investing & Partnering in Biotech & Medtech LEXINGTON, Mass., March 15...
TOPIGEN Announces Appointments of John C. Schafer and Robert J. Deluccia to its Board of Directors Experienced Industry Executives Join Board of...
MacroChem CEO to Participate in Industry Panel on Sexual Dysfunction and Hormone Therapies Annual BIO CEO & Investor Conference to be Held...
MacroChem Announces Initiation of Next Clinical Trial of Opterone(R), First Testosterone Cream For Male Hypogonadism Company plans to initiate...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.